Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name IO102-IO103
Trade Name
Synonyms PD-L1/IDO Peptide Vaccine|IO103/IO102 Peptide Vaccine
Drug Descriptions

IO102-IO103 is a peptide vaccine comprised of long peptides derived from IDO and PD-L1, which may result in activation of IDO and PD-L1 specific T lymphocytes, potentially leading to increased antitumor immune response (Annals of Oncology 31 (2020): S1176).

DrugClasses
CAS Registry Number NA
NCIT ID C148154

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
IO102-IO103 IO102-IO103 0 0
IO102-IO103 + Nivolumab IO102-IO103 Nivolumab 0 1
IO102-IO103 + Nivolumab and relatlimab-rmbw IO102-IO103 Nivolumab and relatlimab-rmbw 0 1
IO102-IO103 + Pembrolizumab IO102-IO103 Pembrolizumab 0 5


Additional content available in CKB BOOST